NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free CPIX Stock Alerts $1.68 -0.11 (-6.15%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$1.68▼$1.8750-Day Range$1.68▼$2.2152-Week Range$1.43▼$2.36Volume4,435 shsAverage Volume12,294 shsMarket Capitalization$23.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cumberland Pharmaceuticals alerts: Email Address Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesMarch 28, 2024 | msn.comNew Cumberland Locks and Dam to have hydroelectric plant by 2027March 28, 2024 | msn.comOfficer involved shooting in Cumberland County ruled justifiedMarch 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 28, 2024 | bizjournals.comUnion: Company threatens to shut Cumberland MineMarch 28, 2024 | yahoo.comLaw enforcement justified in fatal Cumberland County shooting: DAMarch 28, 2024 | msn.comCumberland County District Attorney rules police shooting justifiedMarch 28, 2024 | msn.comCumberland County DA clears officers involved in shooting during Hampden Township domestic incidentMarch 28, 2024 | msn.comCumberland County District Attorney holds news conference about deadly police shootingMarch 29, 2024 | Crypto 101 Media (Ad)Crypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.March 28, 2024 | msn.comBack to Normandy: Cumberland County veteran to mark D-Day 80th anniversary in FranceMarch 27, 2024 | msn.comCumberland County deputies searching for 3 armed suspects in connection with Waffle House robberyMarch 27, 2024 | nj.comCumberland and Salem counties under a flood warning until Wednesday morningMarch 27, 2024 | msn.comCumberland County officials meet to address substance useMarch 27, 2024 | msn.comCumberland County rescue team reacts to Baltimore bridge collapseMarch 27, 2024 | msn.comFor the Love of Fayetteville: Cumberland Coffee Roasters grounds success in communityMarch 26, 2024 | yahoo.comThe fate of Fayetteville’s E.E. Smith: Cumberland commissioner candidates show splitMarch 26, 2024 | msn.comChild bicyclist injured in Cumberland County hit and runMarch 25, 2024 | nj.comCumberland County under a coastal flood advisory until Tuesday afternoonMarch 24, 2024 | usatoday.comRiley Strain’s family thanks Nashville after Missouri student’s body found in Cumberland RiverMarch 24, 2024 | msn.comMissing student Riley Strain's body found in Tennessee's Cumberland RiverMarch 24, 2024 | msn.comCumberland Valley SD student headed to Scripps National Spelling BeeMarch 24, 2024 | msn.comRiley Strain’s family speaks after body found in Cumberland RiverMarch 23, 2024 | usatoday.comMissouri communities mourn after Riley Strain's body found in Nashville's Cumberland RiverMarch 23, 2024 | msn.comBody of Riley Strain found in Cumberland RiverMarch 23, 2024 | nj.comFlood warning for Cumberland and Salem counties until Saturday eveningMarch 23, 2024 | msn.comSlight rise in house prices across Cumberland in JanuaryMarch 23, 2024 | msn.comKinder banking in practice at The CumberlandSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today3/28/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees85Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-15.87% Pretax Margin-15.89% Return on Equity6.84% Return on Assets2.70% Debt Debt-to-Equity Ratio0.44 Current Ratio1.28 Quick Ratio1.11 Sales & Book Value Annual Sales$39.55 million Price / Sales0.60 Cash Flow$0.68 per share Price / Cash Flow2.47 Book Value$1.96 per share Price / Book0.86Miscellaneous Outstanding Shares14,180,000Free Float8,038,000Market Cap$23.82 million OptionableOptionable Beta0.19 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $897.5kMr. John Michael Hamm (Age 68)Chief Financial Officer Comp: $231.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $352.65kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Mr. Adam S. Mostafa (Age 43)Managing Director Mr. Todd M. Anthony (Age 63)Vice President of Organizational Development Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBCalciMedicaNASDAQ:CALCTherapeuticsMDNASDAQ:TXMDIndaptus TherapeuticsNASDAQ:INDPForte BiosciencesNASDAQ:FBRXView All CompetitorsInstitutional OwnershipCitadel Advisors LLCSold 700 shares on 2/15/2024Ownership: 0.000%Dimensional Fund Advisors LPSold 13,786 shares on 2/7/2024Ownership: 2.456%Simplex Trading LLCBought 300 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of the year. Since then, CPIX stock has decreased by 6.2% and is now trading at $1.68. View the best growth stocks for 2024 here. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) issued its quarterly earnings data on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 15.87% and a positive trailing twelve-month return on equity of 6.84%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (2.46%), Citadel Advisors LLC (0.00%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.